Status:

COMPLETED

Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients With a CROS Device on the Contralateral Ear

Lead Sponsor:

University of Colorado, Denver

Conditions:

Hearing Loss, Sensorineural

Eligibility:

All Genders

18-89 years

Phase:

NA

Brief Summary

Speech understanding in noise remains the greatest challenge for people using cochlear implants, particularly when the speech of interest comes from the side of the head opposite to the implant. Recen...

Eligibility Criteria

Inclusion

  • Inclusion Criteria\*:
  • An Advanced Bionics cochlear implant recipient with at least 6 months of listening experience
  • Low frequency Pure Tone Audiometry (PTA)
  • Exclusion Criteria\*:
  • Non-English speakers
  • Additional Inclusion and Exclusion criteria apply

Exclusion

    Key Trial Info

    Start Date :

    January 23 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 11 2021

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT03867396

    Start Date

    January 23 2019

    End Date

    February 11 2021

    Last Update

    May 16 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Colorado School of Medicine

    Aurora, Colorado, United States, 80045